ACR: No Special Benefit Seen with Biologic RA Drugs (CME/CE)
Submitted by MedicalReplies on Tuesday, 20 October 2009No Comment
PHILADELPHIA (MedPage Today) — Patients with rheumatoid arthritis appear to fare equally whether they start treatment with traditional, disease-modifying anti-rheumatic drugs or newer biologic agents that target the basic disease process, researchers said here.
See more here:
ACR: No Special Benefit Seen with Biologic RA Drugs (CME/CE)
Leave your response!